Nu Skin Enterprises (NYSE:NUS – Get Free Report) is scheduled to be issuing its quarterly earnings data after the market closes on Wednesday, February 14th. Analysts expect the company to announce earnings of $0.29 per share for the quarter. Persons that are interested in participating in the company’s earnings conference call can do so using this link.
Nu Skin Enterprises Stock Up 6.4 %
NYSE NUS opened at $18.72 on Tuesday. The company has a current ratio of 1.62, a quick ratio of 0.94 and a debt-to-equity ratio of 0.44. The stock’s 50 day moving average is $18.55 and its two-hundred day moving average is $20.42. Nu Skin Enterprises has a 1-year low of $16.15 and a 1-year high of $45.55. The company has a market capitalization of $924.96 million, a price-to-earnings ratio of 15.60 and a beta of 1.17.
Insider Buying and Selling
In other Nu Skin Enterprises news, Director Andrew D. Lipman sold 2,000 shares of the firm’s stock in a transaction that occurred on Tuesday, December 26th. The shares were sold at an average price of $19.39, for a total value of $38,780.00. Following the transaction, the director now directly owns 33,225 shares of the company’s stock, valued at $644,232.75. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Insiders sold a total of 6,000 shares of company stock valued at $110,100 over the last ninety days. Insiders own 2.80% of the company’s stock.
Hedge Funds Weigh In On Nu Skin Enterprises
Wall Street Analysts Forecast Growth
A number of equities research analysts recently weighed in on the company. TheStreet cut Nu Skin Enterprises from a “c” rating to a “d+” rating in a report on Wednesday, November 1st. DA Davidson lowered their target price on Nu Skin Enterprises from $29.00 to $21.00 and set a “neutral” rating for the company in a research note on Friday, January 5th. Finally, Stifel Nicolaus reduced their price target on shares of Nu Skin Enterprises from $35.00 to $27.00 and set a “hold” rating on the stock in a research report on Monday, October 16th. Four equities research analysts have rated the stock with a hold rating, According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $23.67.
About Nu Skin Enterprises
Nu Skin Enterprises, Inc, together with its subsidiaries, develops and distributes various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO, ageLOC Body Spa; and nutricentials skin care products.
- Five stocks we like better than Nu Skin Enterprises
- What is a Low P/E Ratio and What Does it Tell Investors?
- 3 attractive stocks that insiders are buying
- How to Invest in Music Stocks
- Alpha and Omega Semiconductor ready to bounce, DOJ cloud lifts
- 3 Healthcare Dividend Stocks to Buy
- Wendy’s vs Shake Shack: Out with the new, in with the old?
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.